Needham & Company Reiterates Buy Rating, $20 PT on CorMedix (CRMD), Sees Latest Developments Removing Some Overhang
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| CORMEDIX, Inc. (NASDAQ: CRMD) | Delayed: 5.70 -1.94 (25.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.64 | 52 Week High | $4.54 | |||
| Open | $7.68 | 52 Week Low | $1.15 | |||
| Day High | $7.68 | P/E | N/A | |||
| Day Low | $5.63 | EPS | $-0.55 | |||
| Volume | 7,283,010 | |||||
